111 related articles for article (PubMed ID: 9532262)
1. In-vitro susceptibility of group A beta-haemolytic streptococci (GABHS) to penicillin, erythromycin, clarithromycin and azithromycin in Styria, Austria.
Kriebernegg I; Feierl G; Grisold A; Marth E
Zentralbl Bakteriol; 1998 Jan; 287(1-2):33-9. PubMed ID: 9532262
[TBL] [Abstract][Full Text] [Related]
2. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of group A beta-hemolytic streptococci in the lower St Lawrence region, Quebec.
Desrosiers A; Dolcé P; Jutras P; Jetté LP
Can J Infect Dis; 1999 Jul; 10(4):279-85. PubMed ID: 22346387
[TBL] [Abstract][Full Text] [Related]
5. Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China.
Zhou W; Jiang YM; Wang HJ; Kuang LH; Hu ZQ; Shi H; Shu M; Wa CM
Indian J Med Microbiol; 2014; 32(3):290-3. PubMed ID: 25008823
[TBL] [Abstract][Full Text] [Related]
6. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
Norrby SR; Quinn J; Rangaraju M; Leroy B
Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
Gené A; González-Cuevas A; Juncosa T; Luaces C; Latorre C
Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
[TBL] [Abstract][Full Text] [Related]
9. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance in group A streptococci.
Gerber MA
Pediatr Clin North Am; 1995 Jun; 42(3):539-51. PubMed ID: 7761140
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.
Sauermann R; Gattringer R; Graninger W; Buxbaum A; Georgopoulos A
J Antimicrob Chemother; 2003 Jan; 51(1):53-7. PubMed ID: 12493787
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
Kaya EG; Yücel M; Karakoç AE
Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
[TBL] [Abstract][Full Text] [Related]
15. Incidence of macrolide-lincosamide-streptogramin B resistance amongst beta-haemolytic streptococci in The Gambia.
Foster-Nyarko E; Kwambana B; Ceesay F; Jawneh K; Darboe S; Mulwa SN; Ceesay B; Secka OO; Adetifa I; Antonio M
BMC Res Notes; 2017 Feb; 10(1):106. PubMed ID: 28231812
[TBL] [Abstract][Full Text] [Related]
16. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
17. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
Yazgi H; Ertek M; Aktaş AE
Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin.
Arvand M; Hoeck M; Hahn H; Wagner J
J Antimicrob Chemother; 2000 Oct; 46(4):621-4. PubMed ID: 11020262
[TBL] [Abstract][Full Text] [Related]
19. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Sakran W; Raz R; Colodner R; Keness Y
Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
[TBL] [Abstract][Full Text] [Related]
20. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
